Innogen · People · Innogen Associates
Dr Tim Fell

Chief Executive Officer

t.fell@synthace.com

Synthace Ltd
19 Chalton Street
NW1 1JD
London

uk.linkedin.com/in/timfell1

Tim is an experienced technology venture entrepreneur with an R&D background in both the physical and life sciences. He is CEO of Synthace Ltd, a synthetic biology company that engineers novel biological production systems to manufacture high value, bio-based chemical and biological products. Before joining Synthace he spent 7 years as Chief Operating Officer of CellCentric, a leading epigenetics drug discovery company. Prior to that he was Chief Technology Officer of Arrow Therapeutics and was co-founder and General Manager of DNA microarray tools company Oxford Gene Technology (Operations). Before entering the commercial world Tim spent 13 years performing highly interdisciplinary research at the University of Oxford holding post-doctoral positions in three different departments (Biochemistry, Engineering and Materials). He has a D.Phil in Semiconductor Materials and an MBA from London Business School.

Tim is the Chairman of the UK BioIndustry Association’s Synthetic Biology Advisory Committee and is a member of the Synthetic Biology Leadership Council